Cyclin-Dependent Kinase Inhibitor 2A/B Homozygous Deletion Prediction and Survival Analysis
Cyclin-Dependent Kinase Inhibitor 2A/B (<i>CDKN2A/B</i>) homozygous deletion was a significant prognostic factor for gliomas and affected the treatment strategy. However, the radiomic features of <i>CDKN2A/B</i> homozygous deletion in gliomas have not been developed, and whether the radiomic feature...
Guardado en:
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
MDPI AG
2023-03-01
|
| Colección: | Brain Sciences |
| Materias: | |
| Acceso en línea: | https://www.mdpi.com/2076-3425/13/4/548 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|